{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:56:22Z","timestamp":1773291382694,"version":"3.50.1"},"reference-count":30,"publisher":"The Endocrine Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,2,1]]},"abstract":"<jats:p>Peripheral arterial diseases are caused by arterial sclerosis and impaired collateral vessel formation, which are exacerbated by diabetes, often leading to leg amputation. We have reported that an activation of the natriuretic peptides\/cGMP\/cGMP-dependent protein kinase pathway accelerated vascular regeneration and blood flow recovery in murine legs, for which ischemia had been induced by a femoral arterial ligation as a model for peripheral arterial diseases. In this study, ip injection of carperitide, a human recombinant atrial natriuretic peptide, accelerated blood flow recovery with increasing capillary density in ischemic legs not only in nondiabetic mice but also in mice kept upon streptozotocin-induced hyperglycemia for 16 wk, which significantly impaired the blood flow recovery compared with nondiabetic mice. Based on these findings, we tried to apply the administration of carperitide to the treatment of peripheral arterial diseases. The study group comprised a continuous series of 13 patients with peripheral arterial diseases (Fontaine\u2019s classification I, one; II, five; III, two; and IV, five), for whom conventional therapies had not accomplished appreciable results. Carperitide was administrated continuously and intravenously for 2 wk to Fontaine\u2019s class I\u2013III patients and for 4 weeks to class IV patients. The dose was gradually increased to the maximum, with the patient\u2019s systolic blood pressure being kept above 100 mm Hg. Carperitide administration improved the ankle-brachial pressure index, intermittent claudication, rest pain, and ulcers. In conclusion, this study showed a therapeutic potential of carperitide to treat peripheral arterial diseases refractory to conventional therapies.<\/jats:p>","DOI":"10.1210\/en.2007-1094","type":"journal-article","created":{"date-parts":[[2007,11,9]],"date-time":"2007-11-09T01:25:41Z","timestamp":1194571541000},"page":"483-491","source":"Crossref","is-referenced-by-count":24,"title":["Therapeutic Potential of Atrial Natriuretic Peptide Administration on Peripheral Arterial Diseases"],"prefix":"10.1210","volume":"149","author":[{"given":"Kwijun","family":"Park","sequence":"first","affiliation":[{"name":"Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Itoh","sequence":"additional","affiliation":[{"name":"Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Yamahara","sequence":"additional","affiliation":[{"name":"Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakatsu","family":"Sone","sequence":"additional","affiliation":[{"name":"Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazutoshi","family":"Miyashita","sequence":"additional","affiliation":[{"name":"Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naofumi","family":"Oyamada","sequence":"additional","affiliation":[{"name":"Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"Sawada","sequence":"additional","affiliation":[{"name":"Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Taura","sequence":"additional","affiliation":[{"name":"Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megumi","family":"Inuzuka","sequence":"additional","affiliation":[{"name":"Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuhiro","family":"Sonoyama","sequence":"additional","affiliation":[{"name":"Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Tsujimoto","sequence":"additional","affiliation":[{"name":"Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasutomo","family":"Fukunaga","sequence":"additional","affiliation":[{"name":"Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naohisa","family":"Tamura","sequence":"additional","affiliation":[{"name":"Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuwa","family":"Nakao","sequence":"additional","affiliation":[{"name":"Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2007,11,8]]},"reference":[{"key":"2020071613523082000_R1","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0002-9440(10)65282-0","article-title":"Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF.","volume":"154","author":"Rivard","year":"1999","journal-title":"Am J Pathol"},{"key":"2020071613523082000_R2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/med.10024","article-title":"Abnormal angiogenesis in diabetes mellitus.","volume":"23","author":"Martin","year":"2003","journal-title":"Med Res Rev"},{"key":"2020071613523082000_R3","first-page":"H321","article-title":"Free radicals mediate endothelial cell dysfunction caused by elevated glucose","volume":"263","author":"Tesfamariam","year":"1992","journal-title":"Am J Physiol"},{"key":"2020071613523082000_R4","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1507\/endocrj.48.611","article-title":"The regulation and physiological roles of the guanylyl cyclase receptors.","volume":"48","author":"Tamura","year":"2001","journal-title":"Endocr J"},{"key":"2020071613523082000_R5","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1161\/01.CIR.95.8.2068","article-title":"Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease.","volume":"95","author":"Boger","year":"1997","journal-title":"Circulation"},{"key":"2020071613523082000_R6","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1172\/JCI113544","article-title":"Synthesis of atrial natriuretic polypeptide in human failing hearts. Evidence for altered processing of atrial natriuretic polypeptide precursor and augmented synthesis of \u03b2-human ANP.","volume":"81","author":"Sugawara","year":"1988","journal-title":"J Clin Invest"},{"key":"2020071613523082000_R7","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1172\/JCI115146","article-title":"Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide.","volume":"87","author":"Mukoyama","year":"1991","journal-title":"J Clin Invest"},{"key":"2020071613523082000_R8","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1210\/endo.130.1.1309330","article-title":"Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide.","volume":"130","author":"Suga","year":"1992","journal-title":"Endocrinology"},{"key":"2020071613523082000_R9","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1056\/NEJM200007273430403","article-title":"Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group.","volume":"343","author":"Colucci","year":"2000","journal-title":"N Engl J Med"},{"key":"2020071613523082000_R10","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1253\/circj.69.283","article-title":"Multicenter prospective investigation on efficacy and safety of carperitide for acute heart failure in the \u2018real world\u2019 of therapy.","volume":"69","author":"Suwa","year":"2005","journal-title":"Circ J"},{"key":"2020071613523082000_R11","doi-asserted-by":"crossref","first-page":"H1388","DOI":"10.1152\/ajpheart.00414.2002","article-title":"Physiological concentration of atrial natriuretic peptide induces endothelial regeneration in vitro","volume":"284","author":"Kook","year":"2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2020071613523082000_R12","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1172\/JCI117182","article-title":"Molecular cloning of the complementary DNA and gene that encode mouse brain natriuretic peptide and generation of transgenic mice that overexpress the brain natriuretic peptide gene.","volume":"93","author":"Ogawa","year":"1994","journal-title":"J Clin Invest"},{"key":"2020071613523082000_R13","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1093\/emboj\/17.11.3045","article-title":"Defective smooth muscle regulation in cGMP kinase I-deficient mice.","volume":"17","author":"Pfeifer","year":"1998","journal-title":"EMBO J"},{"key":"2020071613523082000_R14","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1073\/pnas.0538059100","article-title":"Significance and therapeutic potential of the natriuretic peptides\/cGMP\/cGMP-dependent protein kinase pathway in vascular regeneration.","volume":"100","author":"Yamahara","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071613523082000_R15","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1172\/JCI115933","article-title":"Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-\u03b2. Possible existence of \u201cvascular natriuretic peptide system\u201d.","volume":"90","author":"Suga","year":"1992","journal-title":"J Clin Invest"},{"key":"2020071613523082000_R16","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1161\/01.ATV.21.6.930","article-title":"C-type natriuretic peptide induces redifferentiation of vascular smooth muscle cells with accelerated reendothelialization.","volume":"21","author":"Doi","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2020071613523082000_R17","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1161\/01.CIR.0000014985.50017.6E","article-title":"Accelerated reendothelialization with suppressed thrombogenic property and neointimal hyperplasia of rabbit jugular vein grafts by adenovirus-mediated gene transfer of C-type natriuretic peptide.","volume":"105","author":"Ohno","year":"2002","journal-title":"Circulation"},{"key":"2020071613523082000_R18","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1161\/01.CIR.94.12.3103","article-title":"C-type natriuretic peptide in human coronary atherosclerotic lesions.","volume":"94","author":"Naruko","year":"1996","journal-title":"Circulation"},{"key":"2020071613523082000_R19","first-page":"H411","article-title":"Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium","volume":"270","author":"Morbidelli","year":"1996","journal-title":"Am J Physiol"},{"key":"2020071613523082000_R20","doi-asserted-by":"crossref","first-page":"23504","DOI":"10.1074\/jbc.273.36.23504","article-title":"Protein kinase G mediates vascular endothelial growth factor-induced Raf-1 activation and proliferation in human endothelial cells.","volume":"273","author":"Hood","year":"1998","journal-title":"J Biol Chem"},{"key":"2020071613523082000_R21","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1161\/01.ATV.0000122852.22604.78","article-title":"Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited.","volume":"24","author":"Ceriello","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2020071613523082000_R22","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1053\/j.ajkd.2005.05.009","article-title":"Asymmetric dimethylarginine: a cardiovascular risk factor and a uremic toxin coming of age?","volume":"46","author":"Kielstein","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"2020071613523082000_R23","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1073\/pnas.0336365100","article-title":"Release of C-type natriuretic peptide accounts for the biological activity of endothelium-derived hyperpolarizing factor.","volume":"100","author":"Chauhan","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071613523082000_R24","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0022-1759(92)90255-R","article-title":"Superiority of sandwich ELISA over competitive RIA for the estimation of ANP-270, an analogue of human atrial natriuretic factor.","volume":"149","author":"Ingwersen","year":"1992","journal-title":"J Immunol Methods"},{"issue":"Suppl 3","key":"2020071613523082000_R25","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1136\/ard.60.90003.iii68","article-title":"The atrial natriuretic peptide regulates the production of inflammatory mediators in macrophages","volume":"60","author":"Kiemer","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"2020071613523082000_R26","doi-asserted-by":"crossref","first-page":"14452","DOI":"10.1073\/pnas.0504961102","article-title":"C-type natriuretic peptide inhibits leukocyte recruitment and platelet-leukocyte interactions via suppression of P-selectin expression.","volume":"102","author":"Scotland","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071613523082000_R27","doi-asserted-by":"crossref","first-page":"17300","DOI":"10.1073\/pnas.0407894101","article-title":"Critical roles of the guanylyl cyclase B receptor in endochondral ossification and development of female reproductive organs.","volume":"101","author":"Tamura","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071613523082000_R28","first-page":"H2672","article-title":"Estradiol induces C-type natriuretic peptide gene expression in mouse uterus","volume":"273","author":"Acuff","year":"1997","journal-title":"Am J Physiol"},{"key":"2020071613523082000_R29","doi-asserted-by":"crossref","first-page":"H1044","DOI":"10.1152\/ajpheart.00773.2004","article-title":"Marriage of resistance and conduit arteries breeds critical limb ischemia","volume":"288","author":"Coats","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2020071613523082000_R30","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1172\/JCI23360","article-title":"Vascular endothelium is critically involved in the hypotensive and hypovolemic actions of atrial natriuretic peptide.","volume":"115","author":"Sabrane","year":"2005","journal-title":"J Clin Invest"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/149\/2\/483\/8995376\/endo0483.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/149\/2\/483\/8995376\/endo0483.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T05:26:42Z","timestamp":1737523602000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/149\/2\/483\/2454810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11,8]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,2,1]]}},"URL":"https:\/\/doi.org\/10.1210\/en.2007-1094","relation":{},"ISSN":["0013-7227","1945-7170"],"issn-type":[{"value":"0013-7227","type":"print"},{"value":"1945-7170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,11,8]]}}}